UEC: Post Collapse Recovery detected on 3 Sep 2026

UEC is forming a post-collapse recovery pattern with a current price of $11.62, positioned 30.56% above its 52-week low but 42.87% below its 52-week high. The structure score of 12.0/15 and volume score of 12.0/12 indicate solid pattern construction, though the breakout score of 10.51/13 suggests modest technical conviction. Current volume of 8.74M shares is 1.09x average, providing reasonable participation. The pattern sits between key support at $8.95 and resistance at $13.80, with RSI at 50.07 indicating neutral momentum—neither oversold nor overbought conditions.

UEC commenced operations at Burke Hollow, America's largest greenfield ISR uranium project in over a decade, in fiscal Q3 2026. The company maintains a robust balance sheet with $794 million in liquid assets including $488 million in cash and no debt. Strategic uranium inventory position of 1,456,000 pounds of U₃O₈ valued at $127 million, maintaining pricing optionality through an unhedged strategy. Analyst coverage remains supportive with Goldman Sachs maintaining a Buy rating and analysts reiterated a buy rating with a $26.75 price target as of August 26, 2026. The production ramp at Burke Hollow and expanding ISR capacity align with bullish sector regime (0.59 score), though near-term operational execution risk from recent startups may explain recent weakness.

A successful breakout above the $13.80 resistance level would target $12.21 based on conservative measured move, though historical recovery patterns suggest potential for higher levels given the production catalyst tailwind. The pattern indicates a 67.15% win probability. Volume confirmation remains critical—sustained breakout volume above the 1.09x ratio would validate upside movement. Invalidation occurs at $8.95 support; closing below this level would signal failed recovery and potential retest of lower levels. MACD histogram at -0.0402 is mildly negative, so breakout confirmation should include positive histogram crossover.

Goldman Sachs lowered its price target on UEC to $16 from $18, though maintaining a Buy rating, indicating analyst caution despite bullish positioning. The stock's elevated beta of 3.32 creates significant downside amplification in market corrections—a critical concern given neutral overall market regime (0.09 score). Recent 1-week performance of -11.5% and 3-month decline of -17.53% signal ongoing headwinds despite operational progress; production startup execution risks at Burke Hollow could delay margin expansion. High volatility (77.57% 20-day) combined with ultra-high beta makes this vulnerable to sector sentiment shifts. Next key catalyst appears to be Q4 2026 results, which could confirm or disappoint production guidance for the conversion facility expansion.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.